OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
Bidisha Roy, Erica Lee, Teresa Li, et al.
Genes (2022) Vol. 13, Iss. 3, pp. 425-425
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases
Delsuz Rezaee, Fatemeh Saadatpour, Nayyereh Akbari, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102090-102090
Closed Access | Times Cited: 44

MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease
Zahraa Alkhazaali-Ali, Sajad Sahab-Negah, Amir Reza Boroumand, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116899-116899
Open Access | Times Cited: 17

Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4610-4610
Open Access | Times Cited: 53

Non-coding RNAs and neuroinflammation: implications for neurological disorders
Yvonne Chen, Julia Mateski, Linda Gerace, et al.
Experimental Biology and Medicine (2024) Vol. 249
Open Access | Times Cited: 14

Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
Christian Griñán‐Ferré, Aina Bellver‐Sanchís, Ana Guerrero, et al.
Pharmacological Research (2024) Vol. 205, pp. 107247-107247
Open Access | Times Cited: 12

Biomarkers in neurodegenerative diseases: a broad overview
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 10

MicroRNAs in disease States
Mehdi Alizadeh, Hassan Ghasemi, Donya Bazhan, et al.
Clinica Chimica Acta (2025) Vol. 569, pp. 120187-120187
Closed Access | Times Cited: 1

MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 21

Non-Coding RNAs in Human Health and Diseases
Deborah J. Good
Genes (2023) Vol. 14, Iss. 7, pp. 1429-1429
Open Access | Times Cited: 19

MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)
Walter J. Lukiw
Biology (2023) Vol. 12, Iss. 6, pp. 788-788
Open Access | Times Cited: 16

Type 2 Diabetes Mellitus and its comorbidity, Alzheimer’s disease: Identifying critical microRNA using machine learning
Hind Alamro, Vladan Bajić, Mirjana Mačvanin, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 15

Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
Olaia Martínez-Iglesias, Vinogran Naidoo, Iván Carrera, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 216-216
Open Access | Times Cited: 15

Quantum sensing of microRNAs with nitrogen-vacancy centers in diamond
Justas Zalieckas, Martin Greve, Luca Bellucci, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5

Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson’s Disease Pathogenesis and Treatment
Dan Li, Le‐Tian Huang, Cheng-pu Zhang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 20

DECIPHERING THE ROLE OF miRNAs IN ALZHEIMER'S DISEASE: PREDICTIVE TARGETING AND PATHWAY MODULATION - A SYSTEMATIC REVIEW
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Ageing Research Reviews (2024) Vol. 101, pp. 102483-102483
Closed Access | Times Cited: 4

Evaluation of serum miRNAs expression in frail and robust subjects undergoing multicomponent exercise protocol (VIVIFRAIL)
Simone Agostini, Roberta Mancuso, Lorenzo Agostino Citterio, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10

Biochemical study of the effect of mesenchymal stem cells-derived exosome versus l-Dopa in experimentally induced Parkinson’s disease in rats
Asmaa S. Mohamed, Dina Sabry Abdelfattah, Ghada A. Abdel-Aleem, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 12, pp. 2795-2811
Open Access | Times Cited: 10

MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice
Jianwei Ge, Zhiwei Xue, Shu Shu, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 10

Revisiting the Role of miRNAs in Neuropathology
Vineetha George, Vineesh Indira Chandran, Srinivas Gopala
Neurology India (2025) Vol. 73, Iss. 1, pp. 1-4
Closed Access

CircARID1B Promotes MPP+-Induced Death and Inflammation in Dopaminergic Neurons by Elevating MAVS Through Sequestering miR-143-3p
Xuejie Zhang, Xuan Shi, Zhining Liu
Cell Biochemistry and Biophysics (2025)
Closed Access

Unlocking Parkinson’s disease: the role of microRNAs in regulation, diagnosis, and therapy
Xiaodong Li, Qiang Fu, Mei Guo, et al.
APOPTOSIS (2025)
Closed Access

RNA-based therapies for neurodegenerative disease: Targeting molecular mechanisms for disease modification
Vishal Bhati, Sonima Prasad, Atul Kabra
Molecular and Cellular Neuroscience (2025), pp. 104010-104010
Closed Access

Non-coding RNAs: MicroRNAs (miRNAs)
Phei Er Saw, Erwei Song
(2025), pp. 123-141
Closed Access

Page 1 - Next Page

Scroll to top